A phase I and biological correlates study of capecitabine (CAP) plus oxaliplatin (OX) plus radiation therapy (RT) in locally advanced rectal cancer (LARC).

被引：0
|
作者：
Fakih, MG [1 ]
Rajput, A [1 ]
Yang, GY [1 ]
Pendyala, L [1 ]
Toth, K [1 ]
Lawrence, DD [1 ]
Smith, JL [1 ]
Soehnlein, NA [1 ]
Flaherty, L [1 ]
Rustum, YM [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：279S / 279S
页数：1
相关论文
共 50 条
  • [1] Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
    Glynne-Jones, R
    Sebag-Montefiore, D
    Samuel, L
    Falk, S
    Maughan, T
    McDonald, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 252S - 252S
  • [2] A phase II study of capecitabine (CAP) and pre-operative radiation therapy (RT) in resectable, locally advanced rectal cancer (LARC).
    De Paoli, A
    Chiara, S
    Luppi, G
    Friso, ML
    Beretta, G
    Delprete, S
    Pasetto, L
    Frustaci, S
    Santantonio, M
    Corvò, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 255S - 255S
  • [3] Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
    Glynne-Jones, R
    Sebag-Montefiore, D
    McDonald, A
    Falk, S
    Maughan, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 263S - 263S
  • [4] Neoadjuvant chemoradiation therapy with capecitabine (CAP) plus oxaliplatin (OX) in rectal cancer: Final results of a phase II study
    Carlomagno, C.
    D'Armiento, F.
    Farella, A.
    Cannella, L.
    De Stefano, A.
    Colantuoni, M.
    Alfieri, S.
    Marra, M.
    Totaro, G.
    Pepe, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC).
    Shi, GG
    Lin, E
    Eng, C
    Delcos, M
    Crane, C
    Amos, CB
    Brown, T
    Abbruzzese, JL
    Skibber, J
    Janjan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
  • [6] Oxaliplatin plus raltitrexed plus fufa and preoperative concomitant radiotherapy for locally advanced rectal cancer (LARC): A phase I-II study
    Delrio, P
    Avallone, A
    Guida, C
    Marone, P
    Palaia, R
    Tatangelo, F
    Casaretti, R
    Rossi, GB
    Ravo, V
    Petrillo, A
    Budillon, A
    Botti, G
    Tempesta, A
    Lastoria, S
    Morrica, B
    Gomella, G
    Parisi, V
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S67 - S68
  • [7] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Hasegawa, J.
    Kato, T.
    Nishimura, J.
    Yoshioka, S.
    Noura, S.
    Kagawa, Y.
    Yasui, M.
    Ikenaga, M.
    Murata, K.
    Hata, T.
    Matsuda, C.
    Mizushima, T.
    Yamamoto, H.
    Doki, Y.
    Mori, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Junichi Nishimura
    Junichi Hasegawa
    Takeshi Kato
    Shinichi Yoshioka
    Shingo Noura
    Yoshinori Kagawa
    Masayoshi Yasui
    Masakazu Ikenaga
    Kohei Murata
    Taishi Hata
    Chu Matsuda
    Tsunekazu Mizushima
    Hirofumi Yamamoto
    Yuichiro Doki
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 707 - 716
  • [9] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Nishimura, Junichi
    Hasegawa, Junichi
    Kato, Takeshi
    Yoshioka, Shinichi
    Noura, Shingo
    Kagawa, Yoshinori
    Yasui, Masayoshi
    Ikenaga, Masakazu
    Murata, Kohei
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 707 - 716
  • [10] Preoperative chemoradiotherapy (QT-RT) with capecitabine and oxaliplatin (CAPOX) or capecitabine alone (CAP) in patients (PTS) with locally advanced rectal cancer (LARC).
    Marrodan, Ines
    Rubio, Itziar
    Buque, Aitziber
    Sancho, Aintzane
    Fuente, Natalia
    Carrera, Sergio
    Arruti, Mikel
    Manel Mane, Joan
    Isabel Gutierrez, Eddy
    Iruarrizaga, Eluska
    Azkona, Eider
    Lopez-Vivanco, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345